Found 18 matching trials
(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
PHASE3The purpose of this trial is to study the effect of adjuvant or immediate h...
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
PHASE3The purpose of this study is to determine if apalutamide plus gonadotropin ...
Status
Active Not Recruiting
Location
Multiple Locations
Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
PHASE3The purpose of this trial is to study the effect - in terms of time to prog...
A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer.
PHASE2This is a Phase II, multi-center, placebo-controlled randomized controlled ...
Location
CHU de Québec - Université Laval
Bicalutamide Therapy in Young Women With NAFLD and PCOS
PHASE1Nonalcoholic steatohepatitis (NASH), or fat-related liver inflammation and ...
Location
University of California San Francisco
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
PHASE2This partially randomized phase II trial is studying how well giving bicalu...
Location
Rutgers Cancer Institute of New Jersey
Casodex vs Placebo in Non-Metastatic Early Prostate Cancer
PHASE3The purpose of this trial is to study the effect of adjuvant or immediate h...
Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer
PHASE2This randomized, double-blind phase II trial is to assess the efficacy and ...
Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy
PHASE3RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells....
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
PHASE4Dutasteride inhibits the conversion of testosterone to dihydrotestosterone ...
Location
GSK Investigational Site